{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:54:04Z","timestamp":1769018044258,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008545","name":"Georgia State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018655","name":"Southern Economic Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Economics & Human Biology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ehb.2025.101536","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:12:55Z","timestamp":1758600775000},"page":"101536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Expanded prescription coverage and opioid use disorders: Evidence from Medicare Part D"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-2607","authenticated-orcid":false,"suffix":"III","given":"Ricardo B.","family":"Ang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ehb.2025.101536_b1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1475-6773.2011.01244.x","article-title":"The impact of Medicare Part D on hospitalization rates","volume":"46","author":"Afendulis","year":"2011","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.ehb.2025.101536_b2","series-title":"National (nationwide) inpatient sample (nis) database documentation","author":"Agency for Healthcare Research and Quality","year":"2024"},{"key":"10.1016\/j.ehb.2025.101536_b3","series-title":"Opioid use disorder","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.ehb.2025.101536_b4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhealeco.2015.01.006","article-title":"Does prescription drug coverage improve mental health? Evidence from Medicare Part D","volume":"41","author":"Ayyagari","year":"2015","journal-title":"J. Heal. Econ."},{"issue":"4","key":"10.1016\/j.ehb.2025.101536_b5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hec.3326","article-title":"The impact of Medicare Part D on emergency department visits","volume":"26","author":"Ayyagari","year":"2016","journal-title":"Heal. Econ."},{"issue":"3","key":"10.1016\/j.ehb.2025.101536_b6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ehb.2025.101536_b7","series-title":"Preventing opioid overdose","author":"CDC","year":"2025"},{"issue":"3","key":"10.1016\/j.ehb.2025.101536_b8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ehb.2025.101536_b9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108069","article-title":"The impact of Medicare Part D on opioid use among U.S. older adults","volume":"212","author":"Do","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.ehb.2025.101536_b10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1257\/aer.100.1.590","article-title":"The effect of Medicare Part D on pharmaceutical prices and utilization","volume":"100","author":"Duggan","year":"2010","journal-title":"Am. Econ. Rev."},{"key":"10.1016\/j.ehb.2025.101536_b11","series-title":"Opioid use disorder: Evaluation and management","author":"Dydyk","year":"2024"},{"issue":"4","key":"10.1016\/j.ehb.2025.101536_b12","first-page":"77","article-title":"Medicare Part D and the financial protection of the elderly","volume":"3","author":"Engelhardt","year":"2011","journal-title":"Am. Econ. J.: Econ. Policy"},{"issue":"1","key":"10.1016\/j.ehb.2025.101536_b13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/qjec.122.1.1","article-title":"The aggregate effects of health insurance: Evidence from the introduction of Medicare","volume":"122","author":"Finkelstein","year":"2007","journal-title":"Q. J. Econ."},{"key":"10.1016\/j.ehb.2025.101536_b14","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ehb.2025.101536_b15","first-page":"1","article-title":"Examining racial\/ethnic differences in patterns of opioid prescribing: Results from an urban safety-net healthcare system","volume":"9","author":"Flores","year":"2023","journal-title":"J. Racial Ethn. Heal. Disparities"},{"key":"10.1016\/j.ehb.2025.101536_b16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhealeco.2017.07.009","article-title":"Macroeconomic conditions and opioid abuse","volume":"56","author":"Hollingsworth","year":"2017","journal-title":"J. Heal. Econ."},{"key":"10.1016\/j.ehb.2025.101536_b17","unstructured":"ICD9Data.com, ., Nondependent abuse of drugs 305. https:\/\/www.icd9data.com\/2011\/Volume1\/290-319\/300-316\/305\/default.htm."},{"issue":"3","key":"10.1016\/j.ehb.2025.101536_b18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jori.12229","article-title":"Effects of prescription drug insurance on hospitalization and mortality: Evidence from Medicare Part D","volume":"86","author":"Kaestner","year":"2019","journal-title":"J. Risk Insur."},{"issue":"11 SP","key":"10.1016\/j.ehb.2025.101536_b19","first-page":"SP14","article-title":"Medicare Part D\u2019s effects on elderly patients\u2019 drug costs and utilization","volume":"14","author":"Ketcham","year":"2008","journal-title":"Am. J. Manag. Care"},{"issue":"1","key":"10.1016\/j.ehb.2025.101536_b20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5034\/inquiryjrnl_46.01.33","article-title":"Effect of prescription drug coverage on the Elderly\u2019s use of prescription drugs","volume":"46","author":"Khan","year":"2009","journal-title":"Inquiry"},{"issue":"8","key":"10.1016\/j.ehb.2025.101536_b21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hec.4530","article-title":"How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D","volume":"31","author":"Knowles","year":"2022","journal-title":"Heal. Econ."},{"issue":"1","key":"10.1016\/j.ehb.2025.101536_b22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19066","article-title":"Association of medicaid expansion with opioid overdose mortality in the United States","volume":"3","author":"Kravitz-Wirtz","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ehb.2025.101536_b23","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/1475-6773.12710","article-title":"Massachusetts health reform\u2019s effect on hospitalizations with substance use disorder\u2013related diagnoses","volume":"53","author":"Lasser","year":"2018","journal-title":"Health Serv. Res."},{"issue":"4","key":"10.1016\/j.ehb.2025.101536_b24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/geronb\/gbp107","article-title":"Take-up of Medicare Part D: Results from the health and retirement study","volume":"65B","author":"Levy","year":"2010","journal-title":"J. Gerontol.: Ser. B"},{"issue":"6","key":"10.1016\/j.ehb.2025.101536_b25","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1377\/hlthaff.26.6.1735","article-title":"The impact of Medicare Part D on prescription drug use by the elderly","volume":"26","author":"Lichtenberg","year":"2007","journal-title":"Health Aff."},{"key":"10.1016\/j.ehb.2025.101536_b26","series-title":"How opioid addiction occurs","author":"Mayo Clinic","year":"2023"},{"issue":"1","key":"10.1016\/j.ehb.2025.101536_b27","article-title":"Gender differences in the prevalence of heroin and opioid analgesic misuse in the United States","volume":"227","author":"McHugh","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ehb.2025.101536_b28","unstructured":"Medicare.gov, ., Parts of Medicare. https:\/\/www.medicare.gov\/basics\/get-started-with-medicare\/medicare-basics\/parts-of-medicare#:~:text=Part%20A%20(Hospital%20Insurance)%3A,and%20other%20health%20care%20providers."},{"issue":"4","key":"10.1016\/j.ehb.2025.101536_b29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ADM.0000000000000499","article-title":"Predictors for 30-day and 90-day hospital readmission among patients with opioid use disorder","volume":"13","author":"Moreno","year":"2019","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ehb.2025.101536_b30","series-title":"How much does opioid treatment cost?","author":"National Institute on Drug Abuse","year":"2018"},{"key":"10.1016\/j.ehb.2025.101536_b31","series-title":"Medications to treat opioid use disorder research report","author":"National Institute on Drug Abuse","year":"2021"},{"key":"10.1016\/j.ehb.2025.101536_b32","series-title":"Drug overdose deaths: Facts and figures","author":"National Institute on Drug Abuse","year":"2024"},{"key":"10.1016\/j.ehb.2025.101536_b33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2019.102286","article-title":"How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D","volume":"71","author":"Powell","year":"2020","journal-title":"J. Heal. Econ."},{"key":"10.1016\/j.ehb.2025.101536_b34","series-title":"Addiction vs. Dependence","author":"Reed","year":"2025"},{"issue":"S1","key":"10.1016\/j.ehb.2025.101536_b35","doi-asserted-by":"crossref","first-page":"w305","DOI":"10.1377\/hlthaff.28.2.w305","article-title":"The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits","volume":"28","author":"Schneeweiss","year":"2009","journal-title":"Health Aff."},{"issue":"51\u201352","key":"10.1016\/j.ehb.2025.101536_b36","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"10.1016\/j.ehb.2025.101536_b37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCO.0000000000000337","article-title":"Gender differences in prescription opioid use","volume":"30","author":"Serdarevic","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.ehb.2025.101536_b38","unstructured":"Social Security Administration, ., Medicare information. https:\/\/www.ssa.gov\/disabilityresearch\/wi\/medicare.htm."},{"key":"10.1016\/j.ehb.2025.101536_b39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.06.006","article-title":"Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?","volume":"190","author":"Stahler","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ehb.2025.101536_b40","series-title":"Medications for substance use disorders","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"key":"10.1016\/j.ehb.2025.101536_b41","series-title":"Opioid use in Medicare Part D during the onset of the COVID-19 pandemic","author":"United States Department of Health and Human Services","year":"2021"},{"key":"10.1016\/j.ehb.2025.101536_b42","series-title":"Information about medication-assisted treatment (mat)","author":"US Food & Drug Administration","year":"2023"},{"key":"10.1016\/j.ehb.2025.101536_b43","series-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","article-title":"Hospital inpatient stays related to opioid use disorder and endocarditis, 2016","author":"Weiss","year":"2020"},{"issue":"5","key":"10.1016\/j.ehb.2025.101536_b44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jamainternmed.2020.0473","article-title":"Association between medicaid expansion and rates of opioid-related hospital use","volume":"180","author":"Wen","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.ehb.2025.101536_b45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hec.3872","article-title":"Health insurance and opioid deaths: Evidence from the affordable care act young adult provision","volume":"28","author":"Wettstein","year":"2019","journal-title":"Heal. Econ."},{"issue":"3","key":"10.1016\/j.ehb.2025.101536_b46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-148-3-200802050-00200","article-title":"The effect of the Medicare Part D prescription benefit on drug utilization and expenditures","volume":"148","author":"Yin","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.ehb.2025.101536_b47","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1377\/hlthaff.2015.1103","article-title":"Payments for opioids shifted substantially to public and private insurers while consumer spending declined, 1999\u20132012","volume":"35","author":"Zhou","year":"2016","journal-title":"Health Aff."}],"container-title":["Economics & Human Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570677X25000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570677X25000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:39:16Z","timestamp":1768441156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570677X25000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S1570677X25000693"],"URL":"https:\/\/doi.org\/10.1016\/j.ehb.2025.101536","relation":{},"ISSN":["1570-677X"],"issn-type":[{"value":"1570-677X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanded prescription coverage and opioid use disorders: Evidence from Medicare Part D","name":"articletitle","label":"Article Title"},{"value":"Economics & Human Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ehb.2025.101536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101536"}}